Human serum amyloid P component attenuates the bacterial lipopolysaccharide-induced increase in blood-brain barrier permeability in mice

被引:26
作者
Veszelka, S
Urbányi, Z
Pázmány, T
Németh, L
Obál, I
Dung, NTK
Abrahám, CS
Szabó, G
Deli, MA
机构
[1] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, Mol Neurobiol Lab, H-6726 Szeged, Hungary
[2] Richter Gedeon Co, Chem Works, Dept Cell Biol Res, H-1103 Budapest, Hungary
[3] Univ Szeged, Fac Med, Dept Paediat Surg, H-6720 Szeged, Hungary
[4] Hungarian Acad Sci, Inst Expt Med, Dept Funct Neuroanat, Lab Mol Biol & Genet, H-1083 Budapest, Hungary
基金
匈牙利科学研究基金会;
关键词
blood-brain bar; endotoxemia; lipopolysaccharide; mouse; permeability; serum amyloid P component;
D O I
10.1016/j.neulet.2003.08.028
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Endotoxin challenge leads to septic shock, multi-organ failure and death in mice. Permeability of the blood-brain barrier (131313) is increased by endotoxemia. Serum amyloid P component (SAP) is a lipopolysaccharide (LPS)-binding protein that can modulate the host reactions during infections. It is controversial whether SAP can protect from LPS toxicity in vivo or not. We have tested the effect of human SAP on BBB permeability of Salmonella typhimurium LPS-injected mice. The animals showed signs of sickness behaviour including immobility, anorexia, and diarrhoea. Intraperitoneally administered LPS increased the BBB permeability for sodium fluorescein for about 4-fold, and for albumin for more than 2-fold in brain cortex. SAP, given intravenously, had no effect on basal BBB permeability for albumin, although it decreased sodium fluorescein extravasation to brain tissue. In LPS-treated mice, SAP administration alleviated the symptoms of septic shock, and significantly inhibited the enhanced BBB permeability for both tracers. Our data indicate that human SAP may counteract the toxic effects of LPS during septic shock. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:57 / 60
页数:4
相关论文
共 21 条
[1]  
Abraham CS, 1996, NEUROSCI LETT, V208, P85
[2]  
BALTZ ML, 1985, CLIN EXP IMMUNOL, V59, P235
[3]   Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders [J].
Banks, WA .
JOURNAL OF NEUROVIROLOGY, 1999, 5 (06) :538-555
[4]   Adsorptive endocytosis of HIV-1gp120 by blood-brain barrier is enhanced by lipopolysaccharide [J].
Banks, WA ;
Kastin, AJ ;
Brennan, JM ;
Vallance, KL .
EXPERIMENTAL NEUROLOGY, 1999, 156 (01) :165-171
[5]   Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity [J].
Bickerstaff, MCM ;
Botto, M ;
Hutchinson, WL ;
Herbert, J ;
Tennent, GA ;
Bybee, A ;
Mitchell, DA ;
Cook, HT ;
Butler, PJG ;
Walport, MJ ;
Pepys, MB .
NATURE MEDICINE, 1999, 5 (06) :694-697
[6]   Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation [J].
de Haas, CJC ;
van Leeuwen, EMM ;
van Bommel, T ;
Verhoef, J ;
van Kessel, KPM ;
van Strijp, JAG .
INFECTION AND IMMUNITY, 2000, 68 (04) :1753-1759
[7]   New insights into the role of serum amyloid P component, a novel lipopolysaccharide-binding protein [J].
de Haas, CJC .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1999, 26 (3-4) :197-202
[8]  
Deli Maria A., 1996, Keio Journal of Medicine, V45, P183
[9]   Experimental acute pancreatitis results in increased blood-brain barrier permeability in the rat:: a potential role for tumor necrosis factor and interleukin 6 [J].
Farkas, G ;
Márton, J ;
Nagy, Z ;
Mándi, Y ;
Takács, T ;
Deli, MA ;
Abrahám, CS .
NEUROSCIENCE LETTERS, 1998, 242 (03) :147-150
[10]   STRUCTURE AND FUNCTION OF THE PENTRAXINS [J].
GEWURZ, H ;
ZHANG, XH ;
LINT, TF .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (01) :54-64